Anastasia Khvorova, PhD, named 2025 Else Kröner Fresenius Prize for Medical Research awardee for her pioneering work in the field of RNA-based therapies: direc.to/nacK
#EKFprize25 #EKFS #ElseKrönerFreseniusStiftung #RNA #RNAtherapies @ekfstiftung.bsky.social @rti-umasschan.bsky.social
#EKFprize25 #EKFS #ElseKrönerFreseniusStiftung #RNA #RNAtherapies @ekfstiftung.bsky.social @rti-umasschan.bsky.social
Anastasia Khvorova receives 2025 Else Kröner Fresenius Prize for Medical Research
Anastasia Khvorova, PhD, has been awarded the 2025 Else Kröner Fresenius Prize for Medical Research.
direc.to
April 7, 2025 at 3:31 PM
Anastasia Khvorova, PhD, named 2025 Else Kröner Fresenius Prize for Medical Research awardee for her pioneering work in the field of RNA-based therapies: direc.to/nacK
#EKFprize25 #EKFS #ElseKrönerFreseniusStiftung #RNA #RNAtherapies @ekfstiftung.bsky.social @rti-umasschan.bsky.social
#EKFprize25 #EKFS #ElseKrönerFreseniusStiftung #RNA #RNAtherapies @ekfstiftung.bsky.social @rti-umasschan.bsky.social
👩🎓👨🎓 A highlight of #D2RSymposium2025 is student trainees presenting D2R projects through poster presentations. Inspiring to see the next generation of researchers contributing to the conversation on #RNAtherapies!
View the list of poster presentations: www.mcgill.ca/dna-to-rna/c...
View the list of poster presentations: www.mcgill.ca/dna-to-rna/c...
March 13, 2025 at 9:15 PM
👩🎓👨🎓 A highlight of #D2RSymposium2025 is student trainees presenting D2R projects through poster presentations. Inspiring to see the next generation of researchers contributing to the conversation on #RNAtherapies!
View the list of poster presentations: www.mcgill.ca/dna-to-rna/c...
View the list of poster presentations: www.mcgill.ca/dna-to-rna/c...
🔊#D2RProjectSpotlight: From #RNA to personalized #lungdisease treatment
🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD).
🔗https://shorturl.at/yXxOO
#RNA #RNAtherapies
🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD).
🔗https://shorturl.at/yXxOO
#RNA #RNAtherapies
January 13, 2026 at 9:38 PM
🔊#D2RProjectSpotlight: From #RNA to personalized #lungdisease treatment
🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD).
🔗https://shorturl.at/yXxOO
#RNA #RNAtherapies
🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD).
🔗https://shorturl.at/yXxOO
#RNA #RNAtherapies
🎓 We're hiring 2 EDI interns for D2R for Fall 2025!
🕒 12 weeks | 10 hrs/week
💰 $2,500 award
📍 Open to @mcgill.ca students (all faculties)
✍ Apply by July 4: mcgill.ca/equity-ethic...
📧 studentadmin.ihsp@mcgill.ca
#RNAtherapies #Equity #Diversity #Inclusion #internship
🕒 12 weeks | 10 hrs/week
💰 $2,500 award
📍 Open to @mcgill.ca students (all faculties)
✍ Apply by July 4: mcgill.ca/equity-ethic...
📧 studentadmin.ihsp@mcgill.ca
#RNAtherapies #Equity #Diversity #Inclusion #internship
June 11, 2025 at 8:05 PM
🎓 We're hiring 2 EDI interns for D2R for Fall 2025!
🕒 12 weeks | 10 hrs/week
💰 $2,500 award
📍 Open to @mcgill.ca students (all faculties)
✍ Apply by July 4: mcgill.ca/equity-ethic...
📧 studentadmin.ihsp@mcgill.ca
#RNAtherapies #Equity #Diversity #Inclusion #internship
🕒 12 weeks | 10 hrs/week
💰 $2,500 award
📍 Open to @mcgill.ca students (all faculties)
✍ Apply by July 4: mcgill.ca/equity-ethic...
📧 studentadmin.ihsp@mcgill.ca
#RNAtherapies #Equity #Diversity #Inclusion #internship
🎉 Congratulations to the RNAmed doctoral program on securing continued funding from the Elite Network of Bavaria until 2030!
A fantastic achievement for all researchers involved, who are driving forward innovative #RNAtherapies while building strong international collaborations. 🌍🔬
A fantastic achievement for all researchers involved, who are driving forward innovative #RNAtherapies while building strong international collaborations. 🌍🔬
Das Doktorandenkolleg RNAmed erhält bis 2030 eine weitere Förderung vom Elitenetzwerk Bayern – Forschende in frühen Karrierestadien entwickeln darin neue #RNA-Therapien und knüpfen internationale Kontakte. (📷 Luisa Härtig / HIRI) ➡️ www.uni-wuerzburg.de/aktuelles/ei...
August 25, 2025 at 12:33 PM
🎉 Congratulations to the RNAmed doctoral program on securing continued funding from the Elite Network of Bavaria until 2030!
A fantastic achievement for all researchers involved, who are driving forward innovative #RNAtherapies while building strong international collaborations. 🌍🔬
A fantastic achievement for all researchers involved, who are driving forward innovative #RNAtherapies while building strong international collaborations. 🌍🔬
Per la prima volta nella storia, una bambina con #SMA è stata trattata con successo prima della nascita, grazie a una terapia somministrata alla madre.
I risultati sono stati pubblicati sul The New England Journal of Medicine.
#RNAtherapies #ASO
I risultati sono stati pubblicati sul The New England Journal of Medicine.
#RNAtherapies #ASO
RNA therapies: dati di efficacia per il trattamento prenatale per la SMA
La terapia è stata assunta dalla madre in gravidanza e, a due anni e mezzo dalla nascita, la bambina non presenta sintomi della malattia.
www.osservatorioterapieavanzate.it
March 23, 2025 at 11:24 PM
Per la prima volta nella storia, una bambina con #SMA è stata trattata con successo prima della nascita, grazie a una terapia somministrata alla madre.
I risultati sono stati pubblicati sul The New England Journal of Medicine.
#RNAtherapies #ASO
I risultati sono stati pubblicati sul The New England Journal of Medicine.
#RNAtherapies #ASO